PS
BSX icon

Principal Securities’s Boston Scientific BSX Stock Holding History

Principal Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
41,257
+14,316
+53% +$777K 0.02% 597
2026
Q1 		$1.69M Buy
26,941
+255
+1% +$20.4K 0.02% 555
2025
Q4 		$2.54M Buy
26,686
+3,335
+14% +$327K 0.04% 400
2025
Q3 		$2.28M Buy
23,351
+5,564
+31% +$576K 0.04% 407
2025
Q2 		$1.91M Buy
17,787
+7,029
+65% +$711K 0.04% 430
2025
Q1 		$961K Hold
10,758
– – 0.02% 567
2024
Q4 		$961K Buy
10,758
+2,231
+26% +$196K 0.02% 565
2024
Q3 		$715K Buy
8,527
+2,028
+31% +$160K 0.02% 642
2024
Q2 		$500K Buy
6,499
+1,401
+27% +$103K 0.01% 701
2024
Q1 		$349K Buy
5,098
+1,061
+26% +$68.2K 0.01% 806
2023
Q4 		$233K Buy
+4,037
New +$215K 0.01% 888

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Securities's BSX Position: Q2 2026 in Review

Principal Securities increased its Boston Scientific (BSX) stake by 53% in Q2 2026, buying an estimated $777K and bringing the position to 41,257 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #597.

Principal Securities first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.54M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Principal Securities held 41,257 shares of Boston Scientific worth $1.76M as of Q2 2026.
  • Principal Securities bought 14,316 Boston Scientific shares in Q2 2026, an estimated $777K.
  • Boston Scientific made up 0.02% of Principal Securities's portfolio in Q2 2026, its #597 holding.
  • Principal Securities first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's Boston Scientific position peaked at $2.54M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.